MyAverix Finance
F · Healthcare
BioArctic AB (publ) (B9A)
Biotechnology
BioArctic AB (publ) (B9A) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-28, reported market cap is $2.58B, P/E ratio is 27.18, net margin is 51.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for B9A
BioArctic AB (publ) (B9A) — FAQ
What is BioArctic AB (publ)'s market cap?
BioArctic AB (publ) (B9A) has a reported market cap of $2.58B (data as of 2026-03-28).
What is B9A's P/E ratio?
The price-to-earnings (P/E) ratio for BioArctic AB (publ) (B9A) is 27.18 (data as of 2026-03-28).
Does BioArctic AB (publ) pay a dividend?
Dividend yield is not available in the current snapshot for BioArctic AB (publ) (B9A). Check the MyAverix Finance app for the latest dividend data.
What sector is BioArctic AB (publ) in?
BioArctic AB (publ) (B9A) is classified in the Healthcare sector (Biotechnology industry).
What exchange is B9A listed on?
B9A is listed on F.
What is BioArctic AB (publ)'s net margin?
BioArctic AB (publ) (B9A) reports a net margin of 51.1% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.